The typical hurdles our patients are facing is first, getting covered by When asked what steps need to be taken to solve the current GLP-1 medication shortage, Cutler said that fixing it is a complex task due to the complexity of pharmaceutical licensure, manufacturing, and distribution
Ong et al., Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021, The Lancet, vol
Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment With Liraglutide
pain, physical abuse or malnutrition) and emotional stress (e.g
Dual/triple peptides for the treatment of obesity and diabetes Dual glucagon/GLP-1 receptor co-agonists The use of glucagon in patients with type 2 diabetes might seem illogical because of its action of promoting hyperglycaemia
In OA, fibroblast-like synoviocytes and synovial macrophages acquire a pro-inflammatory phenotype, secreting high levels of cytokines and chemokines and prostaglandins, together with matrix-degrading enzymes and nitric oxide
